Massive Bio's Oncology Genomics Advisory Service
Massive Bio has launched an on-demand genomic advisory service for community oncologists. Through the service, the company is offering oncologists assistance with genomic-based test selection and new treatment options after standard approaches like chemotherapy fail. The company is discussing the service at the annual American Society of Clinical Oncology being held in Chicago.
In addition the service, Massive Bio also plans to offer a subscription-based enterprise solution that will be integrated with oncology practices' electronic health record systems. The solution will enable the company's advisory services to be used on a larger scale and in a more automated way. The soultion will be available in early Q3 of this year.